Researchers from McGill University have discovered, for the first time, one of the possible mechanisms that contributes to the ability of lysergic acid diethylamide (LSD) to increase social interaction. The findings, which could help unlock potential therapeutic applications in treating certain psychiatric diseases, including anxiety and alcohol use disorders, are published in the journal PNAS.

Classified as: Research, faculty of medicine, LSD, Gabriella Gobbi, Nahun Sonenberg
Published on: 26 Jan 2021

A group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain, according to researchers from three Canadian universities. The discovery could lead to better and safer treatments for certain patients suffering from major depression.

Classified as: ketamine, depression, antidepressant, brain, Nahum Sonenberg, Gabriella Gobbi
Published on: 16 Dec 2020
Classified as: McGill, Radio-Canada, Gabriella Gobbi
Category:
Published on: 25 Feb 2015

An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.

Classified as: McGill, pain, neurons, chronic pain, melatonin, université mcgill, Gabriella Gobbi, neuropathic pain, opiods, therapy
Category:
Published on: 17 Feb 2015
Back to top